Breast Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head & Neck Cancer, Urothelial Carcinoma​

Quantifying Tumor Cells in Cases With Challenging Histology

In this advanced PD-L1 IHC 22C3 pharmDx Tutorial Video, you will learn to:

  • Assess the number of tumor cells in a highly pleomorphic sample​
  • Estimate tumor cell size using benchmark cells and the appropriate tumor cell count estimates​
  • Consistently and confidently determine the Combined Positive Score (CPS) of pleomorphic cases​

 

Agilent’s PD-L1 IHC 22C3 pharmDx tutorial videos are an engaging and convenient resource for advancing your knowledge of PD-L1 interpretation using Tumor Proportion Score (TPS) and CPS. Through these trainings we will help you to confidently:​

  • Understand the fundamentals of TPS and CPS including key inclusion and exclusion criteria for evaluation​
  • Navigate challenging morphology and staining characteristics​
  • Apply helpful strategies to confidently determine PD-L1 expression levels using TPS and CPS​

Related Training

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.D0113774_1.00